“Media stories describe it for a loophole,” states Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s quite intentional policy.” Brunner has expressed aggravation regarding how some protection of the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicines or investigate peptid